首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Camrelizumab/olaparibLeucopenia, anaemia, and skin rashes: case report
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2022年
/ 1887卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-022-07831-3
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:166 / 166
相关论文
共 50 条
[21]
CiprofloxacinUrticarial rashes: case report
[J].
Reactions Weekly,
2016,
1615
(1)
: 62
-
62
[22]
AlectinibSkin rashes: case report
[J].
Reactions Weekly,
2023,
1946
(1)
: 27
-
27
[23]
CetuximabAcneiform rashes: case report
[J].
Reactions Weekly,
2015,
1550
(1)
: 54
-
54
[24]
PropylthiouracilPruritic rashes: case report
[J].
Reactions Weekly,
2015,
1557
(1)
: 203
-
203
[25]
AzathioprineGeneralised rashes: case report
[J].
Reactions Weekly,
2019,
1752
(1)
: 60
-
60
[26]
Erlotinib/osimertinibAcquired drug resistance, acneform rashes and skin dryness: case report
[J].
Reactions Weekly,
2021,
1855
(1)
: 155
-
155
[27]
IpilimumabAutoimmune haemolytic anaemia and skin toxicity: case report
[J].
Reactions Weekly,
2017,
1653
(1)
: 178
-
178
[28]
Camrelizumab/lenvatinibHypertension: case report
[J].
Reactions Weekly,
2023,
1953
(1)
: 118
-
118
[29]
Camrelizumab/rivoceranibHypothyroidism: case report
[J].
Reactions Weekly,
2023,
1952
(1)
: 111
-
111
[30]
AntineoplasticsLeukocytopenia, thrombocytopenia and rashes: case report
[J].
Reactions Weekly,
2020,
1832
(1)
: 46
-
46
←
1
2
3
4
5
→